With Abdullah's knowledge about genetics and its influence on the way we respond to drugs, him and Flo decided to make genetic information more readily available. The concept of a new service design was born to enable the use of genetic information within the medical practice. The project later received the approval and funding from NHS England.
We wanted to see a change in the way healthcare was delivered. Now we want to change the status quo.
The WHO estimates 50% of patients do not take prescribed medications for fear of side effects, patient - physician communication barriers, lack of information and limited healthcare access. Our service removes these factors, helping patients reach their optimal treatment regimen faster and for our partner doctors to have a complete risk profile for their patients that is objective and evidence based.
United by our passion for health and fitness
A scientist-entrepreneur and a healthcare professional, also a member of the British Heart Foundation Alliance, a member of the Clinical Pharmacogenomics Implementation Consortium in the US, and the inventor of a patent pending-technology for nucleic acid testing on a lateral flow assay (the patent is for a technology to detect DNA sequences in real-time).
Digital Marketing Manager with 5 years experience working on an international scale for both start-up companies and multi-national corporations. Previous experience includes bringing innovative new products and concepts to the international market and developing effective social media and marketing strategies.
Business Development manager at Rightangled Limited with a previous experience in the biotech and pharmaceutical industry. Having previously worked for Janssen Cilag, Novartis and Stallergenes Greer I was involved in developing and delivering campaigns within the medical information departments, rare diseases and batch recall crisis management.
A former pharmacist experiencing the limitations and challenges on the current healthcare system for both the patient and health care professional. Chinda see’s the potential of affordable DNA testing and believes it is the way forward in how medications are prescribed and managed.
A researcher and service designer with a background in industrial design. Flo has over 4 years of experience working for leading design consultancies over the world, where she has provided extensive research and strategy services for leading pharmaceutical companies such as GSK and Novo Nordisk. She also worked in global development with international organisations tackling complex systems.
Scientific, Medical and Advisory
Dr Sibtain Anwar a Senior Lecturer and Consultant in the Department of Perioperative Medicine at the Barts Heart Centre - Europe’s largest cardiovascular institution. He also sits on the Pain Medicine Council at the Royal Society of Medicine. He completed clinical training at Imperial College London, while also pursuing his research interests as an Honorary Fellow of the Academic Cardiology Unit at The National Heart and Lung Institute.
Dr. Ahmed graduated from Barts and the London Medical School in 2005, having also accomplished an intercalated BMedSci (hons) degree in Molecular Therapeutics. He attained membership of the Royal College of Physicians in 2008 and went on to achieve a National training number in Cardiology at the West Midlands Deanery. Since then, he has worked as a cardiology registrar in Birmingham and Coventry. In 2012, he pursued an MD degree at St. George’s, University of London. His research interests are on sports cardiology and in particular the effects of chronic endurance training on the Veteran Athlete.
With a background in Trauma & Orthopaedic surgery, Usman completed his PhD in Medicine with a keen interest in developing and improving diagnostics. He holds a patent for a diagnostic test for skeletal health. He holds his medical degree from Newcastle-upon-Tyne Medical School, a PhD from the University of Warwick, and membership of the Royal College of Surgeons of England.
A former founder and MD of INEOS Healthcare which was based on thedrug he invented. He raised £73mn, grew it from 3 to over 1,000 peopleinvolved working across 23 countries in 250 hospitals before exiting.
Clinical Genetics Consultant at Guy's and St Thomas' NHS FoundationTrust with over 10 years of service in cardiovascular genetics, Dr Leema helped review the literature of our Heart Health Test.
Clinical Genetics Consultant at Guy's and St Thomas' NHSFoundation Trust. Dr Ana is also a Clinical Senior Lecturer at the Division of Craniofacial Development and Stem Cell Biology, King’s College London. Dr Ana helped review the literature of our of our Heart Health Test.
Lead Scientific Advisor, frontline NHS clinician at The Royal FreeHospital and Professor of Nephrology al UCL Medical School. Active researcher with over I 00 papers published in peer reviewed journals. Honorary Fellow of Trinity Hall, University of Cambridge.